Our data suggest that glycolysis‐derived lactate and H3K18la may be potential targets for improving SA‐AKI renal function via inhibition of RhoA/ROCK/Ezrin signaling and Ezrin K263 lactylation mediated by reducing NF‐κB activation. This evidence concerns the gene EZR and acute kidney injury.